"FULL-SERVICE DERMATOLOGY IN TORONTO'S DISTILLERY DISTRICT We see patients for medical and cosmetic dermatology and also offer a unique option—the Rapid Access Clinic. With a referral, patients can walk in (8 AM to 11 AM daily) and be seen by a board-certified dermatologist the same day. There will be a wait, so please be prepared to wait. This is an excellent option for anyone wanting more immediate diagnosis and treatment. Visit our website for must-read details about the Rapid Access Clinic. If you prefer to book an appointment for a specific day, please contact us once you have a referral. We'll schedule you for the next available slot, likely a few weeks from now."

During the past decade, AvantDerm conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AvantDerm" #1 sponsor was "Amgen" with 2 trials, followed by "Asana BioSciences" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Janssen Scientific Affairs, LLC" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AvantDerm" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "AvantDerm" are "Atopic Dermatitis" (4 trials), "Psoriasis" (3 trials), "Dermatitis, Atopic" (2 trials), "Dermatitis" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "AvantDerm" in a lesser frequency.

Most popular intervention types in "AvantDerm" are "Drug" (6 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ASN002" (2 trials), "Lebrikizumab" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "AvantDerm" are 9 trials for "All" genders.

Currently, there are NaN active trials in "AvantDerm". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in AvantDerm, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AvantDerm, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".